<DOC>
	<DOCNO>NCT00689325</DOCNO>
	<brief_summary>To evaluate QOL ( subjective effectiveness ) patient schizophrenia , treat atypical antipsychotic .</brief_summary>
	<brief_title>Evaluating Subjective Well-being Schizophrenic Patients Treated With quetiapineXRÂ® Other Atypical Antipsychotics</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Diagnosis schizophrenia Treatment one atypical antipsychotic* ( first/new episode switch therapy ) least 2 week maximum 8 week prior first study visit . Patient take AAP accord local SPC current medical practice The patient must able understand comply study requirement judge investigator , e.g . patient must able read write Treatment additional AAP AP initial prescribe AAP within 28 week patient include study Since use clozapine limit , due , among thing , risk agranulocytosis , patient treatment '2nd line'AAP exclude . Previous enrolment treatment present NIS Known allergy prescribe AAP substance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>remission</keyword>
	<keyword>subjective well-being effectiveness</keyword>
	<keyword>Quality Life</keyword>
</DOC>